Repository logo
 
Publication

Comparison of Light-Based Devices in the Treatment of Meibomian Gland Dysfunction

2023-07Journal article Open access
Simple item page
dc.contributor.authorCastro, Catarina
dc.contributor.authorMarques, Joao Heitor
dc.contributor.authorMarta, Ana
dc.contributor.authorBaptista, Pedro Manuel
dc.contributor.authorJosé, Diana
dc.contributor.authorSousa, Paulo
dc.contributor.authorMenéres, Pedro
dc.contributor.authorBarbosa, Irene
dc.date.accessioned2024-06-17T15:49:26Z
dc.date.available2024-06-17T15:49:26Z
dc.date.issued2023-07
dc.description.abstractPurpose: To compare different light-based devices, namely, intense pulsed light (IPL) and IPL with low-level light therapy (LLLT), in the treatment of meibomian gland dysfunction (MGD). Methods: This was a prospective, observational study that included patients with MGD. Group 1 included 58 eyes treated with IPL (eye-light®, Espansione Marketing S.p.A., Bologna, Italy), followed by LLLT (my-mask®, Espansione Marketing S.p.A., Bologna, Italy); Group 2 included 60 eyes treated with IPL (E>Eye®, E-Swin, Houdan, France); and Group 3 included 58 eyes treated with IPL (Thermaeye Plus®, OptiMed, Sydney, Australia). The presence of symptoms (Ocular Surface Disease Index (OSDI)) and ocular surface changes were evaluated at baseline, three weeks, and six months after treatment. Results: At week three, there was an improvement in the OSDI in all groups (p<0.001), without differences among them (p=0.339). The lipid layer thickness (LLT) increased in Groups 1 and 2 (p<0.001), with a similar variation (p=0.144). Patients with superior OSDI and lower LLT at baseline had the greatest improvement in the respective parameters (p<0.001). The basal tear flow increased in Group 1 (p=0.012). Corneal staining (CS) significantly decreased in Groups 2 (p<0.001) and 3 (p<0.001). At six months, compared to three weeks, there was further improvement in the OSDI (p<0.001) and the LLT (p=0.007), in Group 1, and an increase in the presence of CS in Group 3 (p=0.011). Conclusion: IPL treatment led to a sustained decrease in patients' symptoms, even after six months. Different IPL devices seem to have different beneficial effects. Adding LLLT to IPL appears to have an additional long-term beneficial effect as well as positive effects on the lacrimal gland.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationCastro C, Marques JH, Marta A, et al. Comparison of Light-Based Devices in the Treatment of Meibomian Gland Dysfunction. Cureus. 2023;15(7):e41386. doi:10.7759/cureus.41386pt_PT
dc.identifier.doi10.7759/cureus.41386pt_PT
dc.identifier.issn2168-8184
dc.identifier.urihttp://hdl.handle.net/10400.16/2933
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherCureus, Inc.pt_PT
dc.relation.publisherversionhttps://www.cureus.com/articles/165209-comparison-of-light-based-devices-in-the-treatment-of-meibomian-gland-dysfunction#!/pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectintense pulsed lightpt_PT
dc.subjectlow-level light therapypt_PT
dc.subjectmeibomian gland dysfunctionpt_PT
dc.subjectocular surface diseasept_PT
dc.subjectocular surface disease indexpt_PT
dc.titleComparison of Light-Based Devices in the Treatment of Meibomian Gland Dysfunctionpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceUnited States of Americapt_PT
oaire.citation.issue7pt_PT
oaire.citation.startPagee41386pt_PT
oaire.citation.titleCureuspt_PT
oaire.citation.volume15pt_PT
person.familyNameMarques
person.familyNameMarta
person.familyNameBaptista
person.familyNameJosé
person.familyNameMeneres
person.familyNameBarbosa
person.givenNameJoao Heitor
person.givenNameAna
person.givenNamePedro Manuel
person.givenNameDiana
person.givenNamePedro
person.givenNameIrene
person.identifier.ciencia-idB112-8980-9E84
person.identifier.orcid0000-0001-6487-7950
person.identifier.orcid0000-0003-3495-4649
person.identifier.orcid0000-0001-8285-1084
person.identifier.orcid0000-0002-8415-0780
person.identifier.orcid0000-0002-1989-3465
person.identifier.orcid0000-0001-6053-5339
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationb1e9a3af-258b-4e7c-9ea6-bb2f67e31bfd
relation.isAuthorOfPublication27861687-928c-4618-9f11-92d74ec326e0
relation.isAuthorOfPublicationaefa59ff-77f9-42ff-ac9b-88373f5c2ac8
relation.isAuthorOfPublication82af911d-7ad4-45a9-9d96-bdbf43ed20ce
relation.isAuthorOfPublicationaddc269e-fbd0-41ae-b58c-46c3500ae580
relation.isAuthorOfPublication0794e8b1-dfb3-41a9-84aa-29915b10c531
relation.isAuthorOfPublication.latestForDiscoveryb1e9a3af-258b-4e7c-9ea6-bb2f67e31bfd

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

SOFT - Artigos publicados em revistas indexadas na Pubmed/Medline